STIM has entered an agreement with Pharmaq Analytiq, a Zoetis subsidiary, to acquire its fish health and environmental services in the UK and Ireland. The acquisition will build on STIM’s business supplying pharmaceuticals and fish health products to aquaculture companies in the UK and Ireland.
STIM and Pharmaq Analytiq are both committed to advancing aquatic health and sustainability. Subject to the completion of the transaction, the Pharmaq Analytiq Veterinary and Environmental services team, along with related operating assets in Inverness, Scotland, and Galway, Ireland will transfer to STIM. STIM’s proposed investment will enhance and broaden their offering, helping them to better deliver on their customers’ needs.
“In Norway, fish health services and environmental services have been an important part of our business for years, and we are delighted to expand our commitment to aquaculture in Scotland and Ireland in the same way. I look forward to collaborating with the experienced Pharmaq Analytiq Veterinary and Environmental services team and welcoming them as colleagues to STIM,” said STIM CEO Carl Erik Arnesen.
“STIM believes in the transformative power of knowledgeable people working together, sharing ideas and experiences. We encourage cross-disciplinary collaboration between our fish health and environmental teams in Norway and across geographies. Our new colleagues in the UK and Ireland will contribute to our common pool of knowledge, furthering our ability to assist the aquaculture industry in achieving improved biological results and sustainable operations,” said Arnesen.
